These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3099313)

  • 1. Specificity of PGE2 analogs interaction between food intake and antisecretory effect.
    Levine RA; Petokas S; Czarny L; Schwartz GJ; Bynum L
    Prostaglandins Leukot Med; 1986 Oct; 24(2-3):219-25. PubMed ID: 3099313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enprostil, a synthetic prostaglandin E2 analogue, inhibits meal-stimulated gastric acid secretion and gastrin release in patients with duodenal ulcer.
    Thomas FJ; Koss MA; Hogan DL; Isenberg JI
    Am J Med; 1986 Aug; 81(2A):44-9. PubMed ID: 3092654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antisecretory effect of a PGE2 derivative, enprostil (TA/RS-84135): inhibitory action of amogastrin-stimulated secretion.
    Kohli Y; Katoh T; Suzuki K
    Drugs Exp Clin Res; 1988; 14(11):673-8. PubMed ID: 3149933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory action of enprostil (4,5-dehydro-16-phenoxy-17,18,19,20-tetranor-PGE2) on tetra-gastrin stimulated acid secretion in human subjects.
    Moriga M; Aono M; Narusawa H; Kohli Y; Kato T; Kajiyama G; Inoue M; Miyoshi A
    Gastroenterol Jpn; 1989 Apr; 24(2):115-9. PubMed ID: 2501133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of low dose of enprostil against gastric blood loss induced by aspirin in man.
    Thiefin G; Fierfort E; Duchateau A; Garbe E; Joubert M; Zeitoun P
    Scand J Gastroenterol; 1989 Sep; 24(7):827-32. PubMed ID: 2508213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central and peripheral effects of prostaglandin E2 and enprostil on gastric acid secretion in the rat.
    Sautereau D; Chicau-Chovet M; Tsocas A; Rozé C
    Eur J Pharmacol; 1991 Mar; 195(2):217-24. PubMed ID: 1678708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of HCO3- secretion by the prostaglandin E2 analog enprostil: studies in human stomach and rat duodenum.
    Heylings JR; Feldman M
    Prostaglandins; 1986 Dec; 32(6):907-17. PubMed ID: 3104991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Intragastric acidity under the prostaglandin E2 analog trimoprostil. Increased inhibitory effect through administration after meals].
    Dammann HG; Walter TA; Wolf N; Müller P; Simon B
    Arzneimittelforschung; 1986 Mar; 36(3):500-2. PubMed ID: 3518730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of postprandial glucose, insulin, C-peptide, and glucose-dependent insulinotropic peptide (GIP) in man by oral administration of a prostaglandin analogue (enprostil).
    Schwartz KE; Zaro B; Reynolds J; Duffy J; Saito T; Hunt JS; Sevelius H
    Horm Metab Res; 1988 Oct; 20(10):637-40. PubMed ID: 3146539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A synthetic prostaglandin E2 analogue, enprostil, hastens gastric emptying of solids in patients with an active duodenal ulcer.
    Nowak A; Jonderko K; Nowakowska-Duława E; Adamczak D; Rudzka J; Nowak S
    Scand J Gastroenterol; 1990 Nov; 25(11):1118-22. PubMed ID: 2125742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and gastric antisecretory properties of allenic 16-phenoxy-omega-tetranor prostaglandin E analogs.
    Carpio H; Cooper GF; Edwards JA; Fried JH; Garay GL; Guzman A; Mendez JA; Muchowski JM; Roszkowski AP; Van Horn AR
    Prostaglandins; 1987 Feb; 33(2):169-80. PubMed ID: 3588969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of enprostil on duodeno-jejunal motility in man.
    Ducrotte P; Parent B; Masliah C; Joubert M; Colin R; Denis P
    Aliment Pharmacol Ther; 1990 Feb; 4(1):73-81. PubMed ID: 2129489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of duodenal ulcer with enprostil, a synthetic prostaglandin E2 analogue.
    Thomson AB
    Am J Med; 1986 Aug; 81(2A):59-63. PubMed ID: 3092657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of enprostil and ranitidine in treatment of duodenal ulcer.
    Bardhan KD; Lee FI; Bose K; Hinchliffe RF; Morris P; Thompson M; Whittaker L; Hardman M; Maxton DG; Colin R
    J Clin Gastroenterol; 1988 Apr; 10(2):137-42. PubMed ID: 3138303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a single oral dose of enprostil on gastric secretion and gastrin release. Studies in healthy volunteers and patients with pernicious anemia.
    Buchanan N; Laferla G; Hearns J; Buchanan KD; Crean GP; McColl KE
    Am J Med; 1986 Aug; 81(2A):40-3. PubMed ID: 3092653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trimoprostil plasma concentration--gastric acid inhibition relationships: potentiation by food.
    Wills RJ; Levine RA; Min BH; Schwartzel EH; Givens SV; Colburn WA; Gallo-Torres HE; Scheinbaum ML
    Clin Pharmacol Ther; 1985 Feb; 37(2):113-7. PubMed ID: 3967453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antisecretory and serum gastrin lowering effect of enprostil in patients with duodenal ulcer disease.
    Mahachai V; Walker K; Sevelius H; Thomson AB
    Gastroenterology; 1985 Sep; 89(3):555-61. PubMed ID: 3926591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of enprostil on gastric emptying, intestinal transit time and post-prandial release of gastro-intestinal peptides.
    Nicholl CG; Carolan G; Sevelius H; Bloom SR
    Digestion; 1989; 43(1-2):47-55. PubMed ID: 2509267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastric antisecretory and antiulcer properties of enprostil, (+/-)-11 alpha, 15 alpha-dihydroxy-16-phenoxy-17,18,19,20-tetranor-9-oxoprosta- 4,5,13(t)-trienoic acid methyl ester.
    Roszkowski AP; Garay GL; Baker S; Schuler M; Carter H
    J Pharmacol Exp Ther; 1986 Nov; 239(2):382-9. PubMed ID: 3095537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of two-week treatment with enprostil (35 micrograms twice a day) on 24-hour serum gastrin levels.
    Florent C; Cogoni C; Joubert M; Desaint B
    Dig Dis Sci; 1990 Nov; 35(11):1352-7. PubMed ID: 2121423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.